Marimed (MRMD) Current Deferred Revenue (2011 - 2026)

Marimed (MRMD) has reported Current Deferred Revenue for 12 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $1.7 million in Q2 2026; TTM through Jun 2026 was $1.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, up 4.89% from the prior year.
• Current Deferred Revenue was $1.7 million for Q2 2026 at Marimed, up from $1.5 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $1.7 million in Q2 2026 and troughed at $1.3 million in Q4 2024.
• A 3-year average of $1.5 million and a median of $1.5 million in 2026 frame the typical range for Current Deferred Revenue.
• The widest YoY moves for Current Deferred Revenue: up 4.89% in 2025, down 4.89% in 2025.
• Over 3 years, Current Deferred Revenue stood at $1.3 million in 2024, then advanced by 4.89% to $1.4 million in 2025, then rose by 22.74% to $1.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $1.7 million (Q2 2026), $1.5 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.